Skip to main content


Continuing Education (CME)

6th Biennial Pediatric Neuro-Oncology Research Conference

June 10-12, 2021

This activity is jointly provided by Global Education Group and Society for Neuro-Oncology 

Target Audience

The educational design of this activity addresses the needs of neuro-oncologists, neurosurgeons, pathologists, scientists, allied health professionals involved in the treatment of pediatric patients with brain tumors.

Statement of Need/Program Overview
The Society for Neuro-Oncology’s 6th Biennial Pediatric Neuro-Oncology Research Conference brings together outstanding leaders in the field of Pediatric Neuro-Oncology and research. Building on the success of our previous pediatric meetings, this biennial conference encourages the sharing of ideas and results, new collaborations, and offers attendees a state-of-the-art update in the field of pediatric brain tumor research. The meeting fosters opportunities to explore collaborations that will positively influence outcomes of Pediatric brain tumor patients. This meeting will be a collaboration of researchers and clinicians disseminating new knowledge to healthcare professionals in order to provide the highest quality of patient care to improve patient outcomes. The goal is to provide healthcare professionals with updated viewpoints, strategies, collaboration opportunities and an increased knowledge base to maximize treatment and management of Pediatric brain tumor patients. 

This year’s meeting will highlight advances in the field of Pediatric Neuro-Oncology from leading Keynote and plenary speakers. The pillars of the meeting will be innovations in the new WHO classifications and development of CAR T cells immunotherapies. 

The purpose of this conference is to provide those interested in the treatment and research of Pediatric patients with updated viewpoints and treatment strategies. Viewpoints and treatment strategies include WHO classifications, immunotherapy and developmental pathways to tumorigenesis. 

Educational Objectives
After completing this activity, the participant should be better able to:

  • Recognize the challenges in the treatment of GBM as it relates to the unique characteristics of the brain tumor microenvironment
  • Recognize new WHO classifications for pediatric CNS tumors in order to manage care accordingly
  • Indicate how to incorporate CAR T cell immunotherapy in pediatric patient treatment plans
  • Identify methods to better assess for and diagnose pediatric familial tumor predisposition

Please click here for the list of Invited Speakers.
Please click here for the list of Keynote Speakers.

Program Agenda
Click here to view current program.  

Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and the Society for Neuro-Oncology. Global is accredited by the ACCME to provide continuing medical education for physicians. 

* This CME/CE activity complies with all requirements of the federal Physician Payment Sunshine Act. If a reportable event is associated with this activity, the accredited provider managing the program will provide the appropriate physician data to the Open Payments database.

Physician Credit Designation
Global Education Group designates this live activity for a maximum of 15.0 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest
Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global.  All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias. 

Global Contact Information
For information about the accreditation of this program, please contact Global at 303-395-1782 or